圣歌
发表于 2025-3-23 11:50:53
http://reply.papertrans.cn/29/2831/283087/283087_11.png
DOLT
发表于 2025-3-23 15:43:04
http://reply.papertrans.cn/29/2831/283087/283087_12.png
gain631
发表于 2025-3-23 21:23:30
D. Creel,H. Spekreijse,D. Reitsaspofungin and micafungin. They have broad spectrum activity against the majority of . and . species and consensus guidelines recommend echinocandins for the treatment of invasive candidiasis, for salvage therapy for invasive aspergillosis and for prophylaxis for invasive candidiasis in select high
无辜
发表于 2025-3-23 22:56:09
http://reply.papertrans.cn/29/2831/283087/283087_14.png
grounded
发表于 2025-3-24 03:35:46
Observations of Faint Globular Clustersmation on the pharmacokinetics (PK) variability or dosing strategies for obese patients. This chapter will briefly outline the literature and dosing recommendations for other miscellaneous antimicrobials that are not presented elsewhere in this book. Dosing recommendations for these agents in obese
勉励
发表于 2025-3-24 07:17:30
Book 2016written by a group of doctors and pharmacists working in infectious diseases practice and research...The introductory chapter outlines the important physiological changes in obesity including factors affecting the dosing of antimicrobials in obese patients. The introductory chapter is followed by te
悬崖
发表于 2025-3-24 13:23:36
M. A. Beran,F. Alayne Street-Perrottstanding of the focus of infection, relative susceptibilities of the micro-organism involved, the best match of the body size descriptor for the antimicrobial in question and the renal function of the patients under treatment.
BLANK
发表于 2025-3-24 15:37:35
H. M. Dekhuijzen,D. R. Verkerke,A. Houwerse significant dose related adverse effects and therefore, the clinical need of a flouroquinolone should be carefully considered before using them in obese patients, who are likely to receive higher than the usually recommended doses.
peak-flow
发表于 2025-3-24 21:13:56
http://reply.papertrans.cn/29/2831/283087/283087_19.png
昏暗
发表于 2025-3-25 01:55:38
Introduction,standing of the focus of infection, relative susceptibilities of the micro-organism involved, the best match of the body size descriptor for the antimicrobial in question and the renal function of the patients under treatment.